These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20855671)

  • 1. Treatment of clinically diagnosed laryngopharyngeal reflux disease.
    Youssef TF; Ahmed MR
    Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1089-92. PubMed ID: 20855671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
    Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients.
    Wang YL; Sheu BS; Huang JJ; Yang HB
    Am J Kidney Dis; 2001 Jul; 38(1):98-103. PubMed ID: 11431188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
    Arenz T; Antos D; Rüssmann H; Alberer M; Buderus S; Kappler M; Koletzko S
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):180-4. PubMed ID: 16877981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
    Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
    Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy.
    Odaka T; Yamaguchi T; Koyama H; Saisho H; Nomura F
    Am J Gastroenterol; 2002 Mar; 97(3):594-9. PubMed ID: 11922552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
    Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC
    Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Esomeprazole based triple therapy for the eradication of helicobacter pylori in patients with non-ulcer dyspepsia].
    De los Ríos R; Pinto J L; Zegarra A; García C; Refulio E; Piscoya A; Huerta-Mercado J; Bussalleu A
    Rev Gastroenterol Peru; 2009; 29(3):234-8. PubMed ID: 19898595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of two rescue therapies for Helicobacter pylori infection.
    Wu DC; Hsu PI; Chen A; Lai KH; Tsay FW; Wu CJ; Lo GH; Wu JY; Wu IC; Wang WM; Tseng HH
    Eur J Clin Invest; 2006 Nov; 36(11):803-9. PubMed ID: 17032348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection].
    Chen YH; Wang WM; Wang H; Li HY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1045-7. PubMed ID: 16109574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
    Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
    Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
    Miehlke S; Hansky K; Schneider-Brachert W; Kirsch C; Morgner A; Madisch A; Kuhlisch E; Bästlein E; Jacobs E; Bayerdörffer E; Lehn N; Stolte M
    Aliment Pharmacol Ther; 2006 Jul; 24(2):395-403. PubMed ID: 16842467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.